The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98080537 9808053 7 F 20140124 20160629 20140110 20160705 EXP US-GLAXOSMITHKLINE-A1055905A GLAXOSMITHKLINE 52.18 YR F Y 0.00000 20160705 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98080537 9808053 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) DOSE: 22 NG/KG/MINCONCENTRATION: 30,000 NG/MLPUMP RATE: 84 ML/DAYVIAL STRENGTH: 1.5 MG U R271A 20444 22 DF POWDER FOR INFUSION
98080537 9808053 2 SS FLOLAN EPOPROSTENOL SODIUM 1 22 NG/KG/MIN, CONTINUOUS U Z606 20444 22 DF POWDER FOR INFUSION
98080537 9808053 3 C REVATIO SILDENAFIL CITRATE 1 U 0
98080537 9808053 4 C AMLODIPINE AMLODIPINE BESYLATE 1 U 0
98080537 9808053 5 C ADCIRCA TADALAFIL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98080537 9808053 1 Cor pulmonale chronic
98080537 9808053 2 Pulmonary hypertension

Outcome of event

Event ID CASEID OUTC COD
98080537 9808053 OT
98080537 9808053 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
98080537 9808053 Catheter removal
98080537 9808053 Central venous catheterisation
98080537 9808053 Cough
98080537 9808053 Device dislocation
98080537 9808053 Device issue
98080537 9808053 Device related infection
98080537 9808053 Dyspnoea
98080537 9808053 Flushing
98080537 9808053 Hospitalisation
98080537 9808053 Infusion site infection
98080537 9808053 Musculoskeletal pain
98080537 9808053 Nausea
98080537 9808053 Pain in extremity
98080537 9808053 Pain in jaw
98080537 9808053 Septic embolus
98080537 9808053 Vein disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98080537 9808053 1 20070906 0